메뉴 건너뛰기




Volumn 77, Issue 6, 2010, Pages 395-399

Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: A Southwest Oncology group study

Author keywords

Carboplatin; Cytoreduction; Neoadjuvant chemotherapy; Ovarian cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

EID: 75549088386     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000279386     Document Type: Article
Times cited : (8)

References (15)
  • 2
    • 0025947320 scopus 로고
    • Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer
    • Jacob JH, Gershenson DM, Morris M, et al: Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol 1991; 42: 146-150.
    • (1991) Gynecol Oncol , vol.42 , pp. 146-150
    • Jacob, J.H.1    Gershenson, D.M.2    Morris, M.3
  • 3
    • 0027327397 scopus 로고
    • Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma
    • Lim JTW, Green JA: Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma. Clin Oncol (R Coll Radiol) 1993; 5: 198-202. (Pubitemid 23271093)
    • (1993) Clinical Oncology , vol.5 , Issue.4 , pp. 198-202
    • Lim, J.T.W.1    Green, J.A.2
  • 4
    • 0032422162 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
    • DOI 10.1006/gyno.1998.5213
    • Vergote I, De Wever I, Tjalma W, et al: Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 1998; 71: 431-436. (Pubitemid 29022333)
    • (1998) Gynecologic Oncology , vol.71 , Issue.3 , pp. 431-436
    • Vergote, I.1    De Wever, I.2    Tjalma, W.3    Van Gramberen, M.4    Decloedt, J.5    Van Dam, P.6
  • 5
    • 46749143864 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery versus upfront surgery followed by chemotherapy (CT) in advanced epithelial ovarian carcinoma (EOC): A prospective randomized study - Interim results (abstract 5531)
    • Kumar L, Hariprasad R, Kumar S, et al: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery versus upfront surgery followed by chemotherapy (CT) in advanced epithelial ovarian carcinoma (EOC): a prospective randomized study - interim results (abstract 5531). J Clin Oncol 2007; 25: 18s.
    • (2007) J Clin Oncol , vol.25
    • Kumar, L.1    Hariprasad, R.2    Kumar, S.3
  • 6
    • 0035889879 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIC ovarian Carcinoma
    • DOI 10.1002/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#
    • Kuhn W, Rutke S, Späthe K, et al: Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 2001; 92: 2585-2591. (Pubitemid 33049442)
    • (2001) Cancer , vol.92 , Issue.10 , pp. 2585-2591
    • Kuhn, W.1    Rutke, S.2    Spaanthe, K.3    Schmalfeldt, B.4    Florack, G.5    Vonhundelshausen, B.6    Pachyn, D.7    Ulm, K.8    Graeff, H.9
  • 8
    • 0035865144 scopus 로고    scopus 로고
    • Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the gynecologic oncology group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
    • Markman M, Bundy B, Alberts D, et al: Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately highdose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001; 19: 1001-1007. (Pubitemid 32176274)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.4 , pp. 1001-1007
    • Markman, M.1    Bundy, B.N.2    Alberts, D.S.3    Fowler, J.M.4    Clark-Pearson, D.L.5    Carson, L.F.6    Wadler, S.7    Sickel, J.8
  • 10
    • 60449103699 scopus 로고    scopus 로고
    • Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009
    • Tiersten AD, Liu PY, Smith HO, et al: Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009. Gynecol Oncol 2009; 112: 444-449.
    • (2009) Gynecol Oncol , vol.112 , pp. 444-449
    • Tiersten, A.D.1    Liu, P.Y.2    Smith, H.O.3
  • 11
    • 0002858680 scopus 로고
    • In vitro determination of drug response: A discussion of clinical applications
    • Fruehauf JP, Bosanquet AG: In vitro determination of drug response: a discussion of clinical applications. PPO Updates 1993; 12: 1-10.
    • (1993) PPO Updates , vol.12 , pp. 1-10
    • Fruehauf, J.P.1    Bosanquet, A.G.2
  • 13
    • 0036919813 scopus 로고    scopus 로고
    • Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients
    • Holloway RW, Mehta RS, Finkler NJ, et al: Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol 2002; 87: 8-16.
    • (2002) Gynecol Oncol , vol.87 , pp. 8-16
    • Holloway, R.W.1    Mehta, R.S.2    Finkler, N.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.